Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    18344568 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES)
Conditions: Hypereosinophilia;   Hypereosinophilic Syndrome
Intervention: Drug: mepolizumab

Study has passed its completion date and status has not been verified in more than two years.